Wed, Aug 30, 2023
Lupin Limited has also received approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application for Pirfenidone Capsules, 267 mg. Lupin will manufacture its Pirfenidone Capsules at its Pithampur facility in India.
More >
Thu, Nov 10, 2022
Lupin Share Price: The drug maker on Wednesday said its consolidated net profit stood at Rs 130 crore for the second quarter ended September 30, 2022.
Mon, Dec 26, 2016
Drug major Lupin has received tentative approval from the US health regulator to sell Olmesartan medoximil tablets, used for treating high blood pressure, in the American market.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
